FDA
Sodium Thiosulfate
The FDA lists this product in 2 strengths and forms.
Indications
Sodium Thiosulfate Injection is indicated for sequential use with sodium nitrite for the treatment of acute cyanide poisoning that is judged to be serious or life-threatening. When the diagnosis of cyanide poisoning is uncertain, the potential risks associated with Sodium Thiosulfate Injection should be carefully weighed against the potential benefits, especially if the patient is not in extremis. Sodium Thiosulfate Injection, an antidote, is indicated for sequential use with sodium nitrite for treatment of acute cyanide poisoning that is judged to be serious or life-threatening.
( 1 ) Use with caution if the diagnosis of cyanide poisoning is uncertain. ( 1 )
Contraindications
None None. ( 4 )
Warnings and precautions
Sulfites: Sodium thiosulfate may contain trace impurities of sodium sulfite ( 5.1 )
5.1Sulfites
Sodium thiosulfate drug product may contain trace impurities of sodium sulfite. The presence of a trace amount of sulfites in this product should not deter administration of the drug for treatment of emergency situations, even if the patient is sulfite-sensitive.
Interactions
Formal drug interaction studies have not been conducted with Sodium Thiosulfate Injection.
Pregnancy and breastfeeding
8.1Pregnancy Risk Summary
There are no available data on Sodium Thiosulfate Injection use in pregnant women to establish a drug-associated risk for major birth defects, miscarriage, or adverse maternal or fetal outcomes. There are risks to the pregnant woman and fetus associated with untreated cyanide poisoning (see Clinical Considerations ). Therefore, if a pregnant woman has known or suspected cyanide poisoning, Sodium Thiosulfate Injection for sequential use with sodium nitrite is recommended [see Indications and Usage (1) ] .
In published animal studies, no evidence of embryotoxicity or malformations was reported when sodium thiosulfate was administered during organogenesis to pregnant mice, rats, hamsters, or rats at 0.2 to 0.9 times the human daily dose of 12.5 g for cyanide poisoning. The studies did not test doses that were comparable to the human dose for cyanide poisoning (see Data ). The estimated background risk of major birth defects and miscarriage for the indicated population is unknown.
At a glance
- Brand name
- Sodium Thiosulfate
- Route
- Intravenous
- Dosage form
- Solution
- Applicant
- Hope Pharms
- Status
- Prescription
- FDA approval
- 14 Feb 2012
- Application
- NDA203923-001



